These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28653260)

  • 1. Contributions of community pharmacists to patients on antidepressants-a qualitative study among key informants.
    Guillaumie L; Moisan J; Grégoire JP; Villeneuve D; Beaucage C; Bordeleau L; Lauzier S
    Int J Clin Pharm; 2017 Aug; 39(4):686-696. PubMed ID: 28653260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: findings from a focus group study.
    Guillaumie L; Moisan J; Grégoire JP; Villeneuve D; Beaucage C; Bujold M; Lauzier S
    Res Social Adm Pharm; 2015; 11(2):e43-56. PubMed ID: 25443641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial factors associated with pharmacists' antidepressant drug treatment monitoring.
    Lauzier S; Guillaumie L; Humphries B; Grégoire JP; Moisan J; Villeneuve D
    J Am Pharm Assoc (2003); 2020; 60(4):548-558. PubMed ID: 32173335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist self-reported antidepressant medication counseling.
    Cannon-Breland ML; Westrick SC; Kavookjian J; Berger BA; Shannon DM; Lorenz RA
    J Am Pharm Assoc (2003); 2013; 53(4):390-9. PubMed ID: 23892812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.
    Quintana-Bárcena P; Lalonde L; Lauzier S
    Res Social Adm Pharm; 2019 Feb; 15(2):145-153. PubMed ID: 29709530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perspectives on the role of community pharmacists for antidepressant treatment: A qualitative study.
    Guillaumie L; Ndayizigiye A; Beaucage C; Moisan J; Grégoire JP; Villeneuve D; Lauzier S
    Can Pharm J (Ott); 2018; 151(2):142-148. PubMed ID: 29531632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
    Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
    Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General practitioners' perceptions of the current status and pharmacists' contribution to primary care in Iceland.
    Blondal AB; Jonsson JS; Sporrong SK; Almarsdottir AB
    Int J Clin Pharm; 2017 Aug; 39(4):945-952. PubMed ID: 28616683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the implementation of a novel optimizing care model in the community pharmacy setting.
    Hohmeier KC; Desselle SP
    J Am Pharm Assoc (2003); 2019; 59(3):310-318. PubMed ID: 30940516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project.
    Pottie K; Haydt S; Farrell B; Kennie N; Sellors C; Martin C; Dolovich L;
    Res Social Adm Pharm; 2009 Dec; 5(4):319-26. PubMed ID: 19962675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of electronic prescribing on the professionalization of community pharmacists: a qualitative study of pharmacists' perception.
    Motulsky A; Winslade N; Tamblyn R; Sicotte C
    J Pharm Pharm Sci; 2008; 11(1):131-46. PubMed ID: 18445369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.
    Kibicho J; Pinkerton SD; Owczarzak J; Mkandawire-Valhmu L; Kako PM
    J Am Pharm Assoc (2003); 2015; 55(1):19-30. PubMed ID: 25575148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of community pharmacists' engagement in pharmacy-delivered influenza vaccination: a mixed-methods study.
    Chadi A; Gabet M; Robitaille A; David PM
    Int J Pharm Pract; 2022 Jan; 30(1):36-44. PubMed ID: 34904643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.